504191 Sigma-AldrichCB1 agonist ACEA - CAS 220556-69-4 - Calbiochem
Sinónimos: N-(2-Chloroethyl)-5Z,8Z,11Z,14Z-eicosatetraenamide
Productos recomendados
Descripción
Replacement Information |
---|
Tabla espec. clave
CAS # | Empirical Formula |
---|---|
220556-69-4 | C₂₂H₃₆ClNO |
Product Information | |
---|---|
CAS number | 220556-69-4 |
Form | Clear to pale yellow liquid |
Formulation | Supplied in MeOAc |
Hill Formula | C₂₂H₃₆ClNO |
Chemical formula | C₂₂H₃₆ClNO |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | CB₁ Receptor |
Primary Target K<sub>i</sub> | 1.4 nM and 3100 nM for CB₁ and CB₂ receptors, respectively. |
Purity | ≥98% by HPLC |
Physicochemical Information |
---|
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
Número de referencia | GTIN |
504191 | 0 |
Documentation
CB1 agonist ACEA - CAS 220556-69-4 - Calbiochem Ficha datos de seguridad (MSDS)
Título |
---|
Referencias bibliográficas
Visión general referencias |
---|
Di Marzo, V., et al. 1998. Trends Neurosci. 21, 521. Mechoulam, R., et al. 1994. Biochem. Pharmacol. 48, 1537. Pertwee, R.G. 1997. Pharmacol. Ther. 74, 129. Fernandez-Ruiz, J., et al. 2000. Trends Neurosci. 23, 14. Song, Z.H., et al. 2000. J. Pharmacol. Exp. Ther. 294, 204. Matsuda, L.A., et al. 1990. Nature 346, 561. Munro, S. et al. 1993. Nature 365, 61. Hillard, C.J., et al. 1999. J. Pharmacol. Exp. Ther. 289, 1427. |